Healthcare provider profile · identity verified

Adam Michael Mitchell, MD

Internal Medicine · HUMBLE, TX · NPI 1104849298

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1033	360
Amlodipine Besylate	Amlodipine Besylate	673	230
Metformin Hcl	Metformin Hcl	560	202
Lisinopril	Lisinopril	493	166
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	475	63
Gabapentin	Gabapentin	417	139
Losartan Potassium	Losartan Potassium	378	136
Levothyroxine Sodium	Levothyroxine Sodium	334	112
Furosemide	Furosemide	310	121
Tizanidine Hcl	Tizanidine Hcl	287	78
Albuterol Sulfate Hfa	Albuterol Sulfate	283	88
Omeprazole	Omeprazole	266	90
Fluticasone Propionate	Fluticasone Propionate	255	98
Tamsulosin Hcl	Tamsulosin Hcl	249	88
Pantoprazole Sodium	Pantoprazole Sodium	232	78
Metoprolol Tartrate	Metoprolol Tartrate	229	76
Metoprolol Succinate	Metoprolol Succinate	227	79
Alprazolam	Alprazolam	220	33
Carvedilol	Carvedilol	203	78
Simvastatin	Simvastatin	199	66
Hydrochlorothiazide	Hydrochlorothiazide	195	68
Glipizide	Glipizide	185	65
Rosuvastatin Calcium	Rosuvastatin Calcium	177	63
Eliquis	Apixaban	170	39
Trazodone Hcl	Trazodone Hcl	168	56
Pravastatin Sodium	Pravastatin Sodium	162	54
Glimepiride	Glimepiride	161	53
Sertraline Hcl	Sertraline Hcl	141	43
Acetaminophen-Codeine	Acetaminophen With Codeine	140	27
Meloxicam	Meloxicam	138	34
Clopidogrel	Clopidogrel Bisulfate	128	49
Diclofenac Sodium	Diclofenac Sodium	127	42
Escitalopram Oxalate	Escitalopram Oxalate	122	42
Sildenafil Citrate	Sildenafil Citrate	122	24
Ozempic	Semaglutide	121	30
Naproxen	Naproxen	120	41
Nifedipine Er	Nifedipine	119	41
Allopurinol	Allopurinol	117	36
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	117	37
Baclofen	Baclofen	112	33
Olmesartan Medoxomil	Olmesartan Medoxomil	110	44
Duloxetine Hcl	Duloxetine Hcl	106	38
Oxybutynin Chloride Er	Oxybutynin Chloride	101	35
Tramadol Hcl	Tramadol Hcl	93	24
Clonazepam	Clonazepam	89	14
Chlorthalidone	Chlorthalidone	85	33
Hydralazine Hcl	Hydralazine Hcl	85	28
Jardiance	Empagliflozin	85	30
Metformin Hcl Er	Metformin Hcl	84	30
Pioglitazone Hcl	Pioglitazone Hcl	81	29
Montelukast Sodium	Montelukast Sodium	80	31
Famotidine	Famotidine	78	31
Potassium Chloride	Potassium Chloride	74	29
Donepezil Hcl	Donepezil Hcl	72	19
Finasteride	Finasteride	69	23
Ibuprofen	Ibuprofen	68	27
Quetiapine Fumarate	Quetiapine Fumarate	67	15
Alendronate Sodium	Alendronate Sodium	66	24
Valsartan	Valsartan	66	21
Triamcinolone Acetonide	Triamcinolone Acetonide	65	32
Atenolol	Atenolol	62	22
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	62	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	23
Prednisone	Prednisone	62	33
Xarelto	Rivaroxaban	62	13
Pregabalin	Pregabalin	61	19
Spironolactone	Spironolactone	57	21
Lorazepam	Lorazepam	55	20
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	53	17
Clonidine Hcl	Clonidine Hcl	53	19
Ezetimibe	Ezetimibe	53	21
Fluoxetine Hcl	Fluoxetine Hcl	53	20
Mirtazapine	Mirtazapine	53	18
Ketoconazole	Ketoconazole	52	22
Warfarin Sodium	Warfarin Sodium	51	14
Buspirone Hcl	Buspirone Hcl	50	16
Lovastatin	Lovastatin	50	16
Farxiga	Dapagliflozin Propanediol	49	14
Venlafaxine Hcl Er	Venlafaxine Hcl	48	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	44	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Celecoxib	Celecoxib	36	13
Memantine Hcl	Memantine Hcl	35	12
Januvia	Sitagliptin Phosphate	34	12
Methylprednisolone	Methylprednisolone	34	31
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	30
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Torsemide	Torsemide	32	11
Azithromycin	Azithromycin	30	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	12
Doxazosin Mesylate	Doxazosin Mesylate	30	11
Trulicity	Dulaglutide	30	suppressed
Lamotrigine	Lamotrigine	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	12
Amoxicillin	Amoxicillin	27	21
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	27	suppressed
Benazepril Hcl	Benazepril Hcl	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	12
Tresiba Flextouch U-100	Insulin Degludec	26	suppressed
Glipizide Er	Glipizide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	14
Tradjenta	Linagliptin	24	suppressed
Novolog Flexpen	Insulin Aspart	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	22
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	22	12
Valacyclovir	Valacyclovir Hcl	22	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Acyclovir	Acyclovir	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Topiramate	Topiramate	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Azelastine Hcl	Azelastine Hcl	18	13
Olanzapine	Olanzapine	18	suppressed
Tresiba Flextouch U-200	Insulin Degludec	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Bumetanide	Bumetanide	17	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	16
Glipizide-Metformin	Glipizide/Metformin Hcl	17	suppressed
Hydrocortisone	Hydrocortisone	17	11
Novolin N Flexpen	Insulin Nph Human Isophane	17	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Cefuroxime	Cefuroxime Axetil	16	15
Fenofibrate	Fenofibrate	16	suppressed
Nystatin	Nystatin	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Clonidine	Clonidine	15	suppressed
Etodolac	Etodolac	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Oxycodone Hcl	Oxycodone Hcl	15	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	14
Clotrimazole	Clotrimazole	14	13
Estradiol	Estradiol	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Novolin N	Insulin Nph Human Isophane	14	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Risperidone	Risperidone	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Diazepam	Diazepam	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Desonide	Desonide	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Piroxicam	Piroxicam	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error